Your browser doesn't support javascript.
loading
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
Pagani, Ilaria S; Shanmuganathan, Naranie; Dang, Phuong; Saunders, Verity A; Grose, Randall; Kok, Chung H; James, Jane; Tolland, Molly; Braley, Jodi A; Altamura, Haley K; Yeung, David T; Branford, Susan; Yong, Agnes S M; Hughes, Timothy P; Ross, David M.
Afiliación
  • Pagani IS; Precision Cancer Medicine Theme, Blood Cancer Program, Chronic Myeloid Leukaemia Research Group, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Shanmuganathan N; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia.
  • Dang P; Precision Cancer Medicine Theme, Blood Cancer Program, Chronic Myeloid Leukaemia Research Group, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Saunders VA; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia.
  • Grose R; Department of Haematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Kok CH; Genetic and Molecular Pathology, SA Pathology, SA, Adelaide, Australia.
  • James J; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA, Australia.
  • Tolland M; Precision Cancer Medicine Theme, Blood Cancer Program, Chronic Myeloid Leukaemia Research Group, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Braley JA; Precision Cancer Medicine Theme, Blood Cancer Program, Chronic Myeloid Leukaemia Research Group, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Altamura HK; Precision Cancer Medicine Theme, Blood Cancer Program, Chronic Myeloid Leukaemia Research Group, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Yeung DT; Precision Cancer Medicine Theme, Blood Cancer Program, Chronic Myeloid Leukaemia Research Group, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Branford S; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia.
  • Yong ASM; Precision Cancer Medicine Theme, Blood Cancer Program, Chronic Myeloid Leukaemia Research Group, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Hughes TP; Precision Cancer Medicine Theme, Blood Cancer Program, Chronic Myeloid Leukaemia Research Group, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Ross DM; School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia.
Blood ; 142(25): 2192-2197, 2023 12 21.
Article en En | MEDLINE | ID: mdl-37616555
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article País de afiliación: Australia